GaldermaDeliversRecord2025ResultsWithNetSalesof5.207BillionUSD,up17.7%atConstantCurrency1,andCoreEBITDA2of1.211billionUSD,Growing18.9%atConstantCurrency
===2026/3/5 16:11:22===
x 4: Reconciliation of FY 2025 of Core EBITDA to IFRS Net Income
In million USD
FY 2024
FY2025
Core EBITDA
1,031
1,211
% margin
23.4%
23.3%
Exceptional and transformation related adjustments
(60)
(16)
Other income / (expenses) excl. impairment
(33)
(43)
Total EBITDA adjustments8
=*=*=*=*=*=
当前为第37/55页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页